The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savings

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 2, 2000, Pages 439-442

  Giles, Warwick ^a   Bisits, Andrew ^a   Knox, Marianne ^a   Madsen, Gemma ^a   Smith, Roger ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Cost savings; Fetal fibronectin; Maternal transfer; Preterm labor

Indexed keywords

FIBRONECTIN;

ARTICLE; COST CONTROL; DIAGNOSTIC VALUE; FEMALE; FETOPLACENTAL UNIT; HUMAN; MAJOR CLINICAL STUDY; PREMATURE LABOR; PRIORITY JOURNAL; UTERINE CERVIX DILATATION; VAGINA SECRETION;

EID: 85047699515     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(00)70236-5     Document Type: Article

References (17)

1. 1. Lockwood CJ. Recent advances in elucidating the pathogenesis of preterm delivery, the detection of patients at risk, and preventative therapies. Curr Opin Obstet Gynecol 1994; 6:7-18.
2. 2. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 1997;177:13-8.
3. 3. Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Meis PJ, Das A, et al. The Preterm Prediction Study: patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1997;177:8-12.
4. 4. Iams JD, Goldenberg RL, Mercer BM, Moawad AH, Thom E, Meis PJ, et al. The Preterm Prediction Study: recurrence risk of spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1998;178:1035-40.
5. 5. Jackson GM, Edwin SS, Varmer MW, Casal D, Mitchell MD. Regulation of fetal fibronectin production in human amnion cells. J Soc Gynecol Investig 1996;3:85-8.
6. 6. Eriksen NL, Parisi VM, Daoust S, Flamm B, Garite TJ, Cox SM. Fetal fibronectin: a method for detecting the presence of amniotic fluid. Obstet Gynecol 1992;80:451-4.
7. 7. Morrison JC, Allbert JR, McLaughlin BN, Whitworth NS, Roberts WE, Martin RW. Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol 1993;168:538-42.
8. 8. Ascarelli MH, Morrison JC. Use of fetal fibronectin in clinical practice. Obstet Gynecol Surv 1997;52:S1-12.
9. 9. Benattar C, Taieb J, Fernandez H, Lindendaum A, Frydman R, Ville Y. Rapid fetal fibronectin swab-test in preterm labour patients treated by betamimetics. Eur J Obstet Gynecol Reprod Biol 1997;72:131-5.
10. 10. Greenhagen JB, Van Wagoner J, Dudley D, Hunter C, Mitchell M, Logsdon V, et al. Value of fetal fibronectin as a predictor of preterm delivery for a low-risk population. Am J Obstet Gynecol 1996;175:1054-6.
11. 11. Parker J, Bell R, Brennecke S. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks gestation. Aust N Z J Obstet Gynaecol 1995;35:257-61.
12. 12. Lukes AS, Thorp JM Jr, Eucker B, Pahel-Short L. Predictors of positivity for fetal fibronectin in patients with symptoms of preterm labor. Am J Obstet Gynecol 1997;176:639-41.
13. 13. Faron G, Boulvain M, LescrainerJP, Vokaer A. A single cervical fetal fibronectin screening test in a population at low risk for preterm delivery: an improvement on clinical indicators? Br J Obstet Gynaecol 1997;104:697-701.
14. 14. Bisits A, Madsen G, McLean M, O'Callaghan S, Smith R, Giles W. Corticotropin-releasing hormone: a biochemical predictor of preterm delivery in a pilot randomized trial of the treatment of preterm labor. Am J Obstet Gynecol 1998; 178:862-6.
15. 15. Chien PF, Khan KS, Ogston S, Owen P. The diagnostic accuracy of cervico-vaginal fetal fibronectin in predicting preterm delivery: an overview. Br J Obstet Gynaecol 1997;104:436-44.
16. 16. Owen P, Scott A. Can fetal fibronectin testing improve the management of preterm labour? Clin Exp Obstet Gynecol 1997;24:19-22.
17. 17. Bittar RE, Yamasaki AA, Sasaki S, Zugaib M. Cervical fetal fibronectin in patients at increased risk for preterm delivery. Am J Obstet Gynecol 1996;175:178-81.